At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 40 enrolled
Drug / intervention
Sham light +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Non-ablative Light Source for the Treatment of Rhytides (Wrinkles)
In Brief
A Phase 3 clinical trial evaluating Sham light and LumiPhase-R™, OPUSMED Inc. Montreal, Canada for Skin Aging and Photoaging of Skin. Completed, enrolled 40 participants across 1 site.
Detailed Summary
The purpose of this study was to determine whether light emitting diode (LED) therapy can improve skin appearance of human subjects with aged/photoaged skin. A reduction in rhytid depth as well as in skin surface roughness and in the degree of elastosis after LED treatments was expected.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSkin Aging, Photoaging of Skin
CountriesCanada
Collaborators--
Timeline
Phase 3CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedJan 2009
TodayJul 2026
First PostedJan 7, 2009
TodayJul 2, 2026
Posted 17.5 years ago
Interventions
Sham lightdevice
LumiPhase-R™, OPUSMED Inc. Montreal, Canadadevice
660 nm wavelength delivered in a sequential pulsing mode